(2S)-N-[(3S,4S)-7-cyano-5-(4-cyanobenzoyl)-1-[[1-(2-cyanophenyl)indazol-3-yl]methyl]-4-methyl-2-oxo-3,4-dihydro-1,5-benzodiazepin-3-yl]-2-(methylamino)propanamide

C38H31N9O3 — CID 90082461

IUPAC(2S)-N-[(3S,4S)-7-cyano-5-(4-cyanobenzoyl)-1-[[1-(2-cyanophenyl)indazol-3-yl]methyl]-4-methyl-2-oxo-3,4-dihydro-1,5-benzodiazepin-3-yl]-2-(methylamino)propanamide
SMILESCN[C@@H](C)C(=O)N[C@@H]1C(=O)N(Cc2nn(-c3ccccc3C#N)c3ccccc23)c2ccc(C#N)cc2N(C(=O)c2ccc(C#N)cc2)[C@H]1C
InChIInChI=1S/C38H31N9O3/c1-23(42-3)36(48)43-35-24(2)46(37(49)27-15-12-25(19-39)13-16-27)34-18-26(20-40)14-17-33(34)45(38(35)50)22-30-29-9-5-7-11-32(29)47(44-30)31-10-6-4-8-28(31)21-41/h4-18,23-24,35,42H,22H2,1-3H3,(H,43,48)/t23-,24-,35-/m0/s1
InChIKeyPWHIXNXPTSFUEC-ZHCZTUKZSA-N
MW661.73 g/mol
LogP4.32
Rot. Bonds7

About (2S)-N-[(3S,4S)-7-cyano-5-(4-cyanobenzoyl)-1-[[1-(2-cyanophenyl)indazol-3-yl]methyl]-4-methyl-2-oxo-3,4-dihydro-1,5-benzodiazepin-3-yl]-2-(methylamino)propanamide

(2S)-N-[(3S,4S)-7-cyano-5-(4-cyanobenzoyl)-1-[[1-(2-cyanophenyl)indazol-3-yl]methyl]-4-methyl-2-oxo-3,4-dihydro-1,5-benzodiazepin-3-yl]-2-(methylamino)propanamide (PubChem CID 90082461) has the molecular formula C38H31N9O3 and a molecular weight of 661.73 g/mol. Its IUPAC name is (2S)-N-[(3S,4S)-7-cyano-5-(4-cyanobenzoyl)-1-[[1-(2-cyanophenyl)indazol-3-yl]methyl]-4-methyl-2-oxo-3,4-dihydro-1,5-benzodiazepin-3-yl]-2-(methylamino)propanamide.

Molecular Properties

Compound Name(2S)-N-[(3S,4S)-7-cyano-5-(4-cyanobenzoyl)-1-[[1-(2-cyanophenyl)indazol-3-yl]methyl]-4-methyl-2-oxo-3,4-dihydro-1,5-benzodiazepin-3-yl]-2-(methylamino)propanamide
PubChem CID90082461
Molecular FormulaC38H31N9O3
Molecular Weight661.73 g/mol
Exact Mass661.25
IUPAC Name(2S)-N-[(3S,4S)-7-cyano-5-(4-cyanobenzoyl)-1-[[1-(2-cyanophenyl)indazol-3-yl]methyl]-4-methyl-2-oxo-3,4-dihydro-1,5-benzodiazepin-3-yl]-2-(methylamino)propanamide
SMILESCN[C@@H](C)C(=O)N[C@@H]1C(=O)N(Cc2nn(-c3ccccc3C#N)c3ccccc23)c2ccc(C#N)cc2N(C(=O)c2ccc(C#N)cc2)[C@H]1C
InChIInChI=1S/C38H31N9O3/c1-23(42-3)36(48)43-35-24(2)46(37(49)27-15-12-25(19-39)13-16-27)34-18-26(20-40)14-17-33(34)45(38(35)50)22-30-29-9-5-7-11-32(29)47(44-30)31-10-6-4-8-28(31)21-41/h4-18,23-24,35,42H,22H2,1-3H3,(H,43,48)/t23-,24-,35-/m0/s1
InChIKeyPWHIXNXPTSFUEC-ZHCZTUKZSA-N
XLogP4.32
TPSA170.94 Ų
H-Bond Donors2
H-Bond Acceptors9
Rotatable Bonds7
Heavy Atoms50
Complexity—

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500661.73
LogP ≤ 54.32
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 109

Analyze (2S)-N-[(3S,4S)-7-cyano-5-(4-cyanobenzoyl)-1-[[1-(2-cyanophenyl)indazol-3-yl]methyl]-4-methyl-2-oxo-3,4-dihydro-1,5-benzodiazepin-3-yl]-2-(methylamino)propanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (2S)-N-[(3S,4S)-7-cyano-5-(4-cyanobenzoyl)-1-[[1-(2-cyanophenyl)indazol-3-yl]methyl]-4-methyl-2-oxo-3,4-dihydro-1,5-benzodiazepin-3-yl]-2-(methylamino)propanamide?
The IUPAC name of (2S)-N-[(3S,4S)-7-cyano-5-(4-cyanobenzoyl)-1-[[1-(2-cyanophenyl)indazol-3-yl]methyl]-4-methyl-2-oxo-3,4-dihydro-1,5-benzodiazepin-3-yl]-2-(methylamino)propanamide (CID 90082461) is (2S)-N-[(3S,4S)-7-cyano-5-(4-cyanobenzoyl)-1-[[1-(2-cyanophenyl)indazol-3-yl]methyl]-4-methyl-2-oxo-3,4-dihydro-1,5-benzodiazepin-3-yl]-2-(methylamino)propanamide.
What is the SMILES notation for (2S)-N-[(3S,4S)-7-cyano-5-(4-cyanobenzoyl)-1-[[1-(2-cyanophenyl)indazol-3-yl]methyl]-4-methyl-2-oxo-3,4-dihydro-1,5-benzodiazepin-3-yl]-2-(methylamino)propanamide?
The canonical SMILES for (2S)-N-[(3S,4S)-7-cyano-5-(4-cyanobenzoyl)-1-[[1-(2-cyanophenyl)indazol-3-yl]methyl]-4-methyl-2-oxo-3,4-dihydro-1,5-benzodiazepin-3-yl]-2-(methylamino)propanamide is CN[C@@H](C)C(=O)N[C@@H]1C(=O)N(Cc2nn(-c3ccccc3C#N)c3ccccc23)c2ccc(C#N)cc2N(C(=O)c2ccc(C#N)cc2)[C@H]1C.
What is the InChIKey of (2S)-N-[(3S,4S)-7-cyano-5-(4-cyanobenzoyl)-1-[[1-(2-cyanophenyl)indazol-3-yl]methyl]-4-methyl-2-oxo-3,4-dihydro-1,5-benzodiazepin-3-yl]-2-(methylamino)propanamide?
The InChIKey is PWHIXNXPTSFUEC-ZHCZTUKZSA-N. The full InChI is InChI=1S/C38H31N9O3/c1-23(42-3)36(48)43-35-24(2)46(37(49)27-15-12-25(19-39)13-16-27)34-18-26(20-40)14-17-33(34)45(38(35)50)22-30-29-9-5-7-11-32(29)47(44-30)31-10-6-4-8-28(31)21-41/h4-18,23-24,35,42H,22H2,1-3H3,(H,43,48)/t23-,24-,35-/m0/s1.
What are the key properties of (2S)-N-[(3S,4S)-7-cyano-5-(4-cyanobenzoyl)-1-[[1-(2-cyanophenyl)indazol-3-yl]methyl]-4-methyl-2-oxo-3,4-dihydro-1,5-benzodiazepin-3-yl]-2-(methylamino)propanamide?
(2S)-N-[(3S,4S)-7-cyano-5-(4-cyanobenzoyl)-1-[[1-(2-cyanophenyl)indazol-3-yl]methyl]-4-methyl-2-oxo-3,4-dihydro-1,5-benzodiazepin-3-yl]-2-(methylamino)propanamide has a molecular weight of 661.73 g/mol, XLogP of 4.32, 7 rotatable bonds, 2 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for (2S)-N-[(3S,4S)-7-cyano-5-(4-cyanobenzoyl)-1-[[1-(2-cyanophenyl)indazol-3-yl]methyl]-4-methyl-2-oxo-3,4-dihydro-1,5-benzodiazepin-3-yl]-2-(methylamino)propanamide is sourced from PubChem (CID 90082461), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).